Resistance to quinolones and beta-lactams in Salmonella enterica due to mutations in topoisomerase-encoding genes, altered cell permeability and expression of an active efflux system;Resistencia a quinolonas y betalactámicos en Salmonella enterica, y su relación con mutaciones en las topoisomerasas, alteraciones en la permeabilidad celular y expresión de un mecanismo de expulsión activa

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 22, Issue 4, 2004, Pages 204-211

  Miró, Elisenda ^a   Vergés, Clara ^a   García, Isabel ^b   Mirelis, Beatriz ^a   Navarro, Ferrán ^a   Coll, Pere ^a   Prats, Guillermo ^a,d   Martínez Martínez, Luis ^b,c,e  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Efflux inhibitors; Efflux pumps; Porins; Quinolones; Salmonella; Topoisomerases

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CHLORAMPHENICOL; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; GENE PRODUCT; METRONIDAZOLE; NALIDIXIC ACID; NORFLOXACIN; OUTER MEMBRANE PROTEIN; PEFLOXACIN; PORIN; PROTEIN PARC; PROTEIN PARE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM ISOLATE; CASE REPORT; CELL MEMBRANE PERMEABILITY; COLORIMETRY; ENTERITIS; ESCHERICHIA COLI; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PROTEIN EXPRESSION; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA ENTERICA; SEROTYPING;

EID: 2342503958     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13059049     Document Type: Article

References (44)

1. Heisig P. High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes. J Antimicrob Chemother 1993;32:367-77.
2. Giraud E, Brisabois A, Martel JL, Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother 1999;43:2131-7.
3. Piddock LJV. Flouroquinolone resistance in Salmonella serovars isolated from humans and food animals. FEMS Microbiol Rev 2002;26:3-16.
4. Navarro F, Miró E, Mirelis B. Lectura Interpretada del antibiograma de enterobacterias. Enferm Infecc Microbiol Clin 2002;20:225-34.
5. Alekshun MN, Levy SB. Regulation of chromosomally mediated multiple antibiotic resistance: The mar regulon. Antimicrob Agents Chemother 1997;41:2067-75.
6. Nikaido H. Antibiotic resistance caused by gram-negative multidrug efflux pumps. Clin Infect Dis 1998;27(Suppl 1):32-41.
7. Martínez JL, Alonso A, Gómez-Gómez JM, Baquero F. Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg? J Antimicrob Chemother 1998;42:683-8.
8. Martínez-Martínez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet 1998;351:797-9.
9. Tran JH, Jacoby GA. Mechanism of plasmid mediated quinolone resistance. Proc Natl Acad Sci USA 2002;99:5638-42.
10. Gensberg K JY, Piddock LJ. A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium. FEMS Microbiol Lett 1995;132:293.
11. Piddock LJV, Ricci V, McLaren I, Griggs DJ. Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom. J Antimicrob Chemother 1998;41:635-41.
12. Ruiz J, Castro D, Goni P, Santamaría JA, Borrego JJ, Vila J. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium. J Med Microbiol 1997;46:623-8.
13. Reyna F, Huesca M, González V, Fuchs LY. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance. Antimicrob Agents Chemother 1995;39:1621-3.
14. Guerra B, Malorny B, Schroeter A, Helmuth R. Multiple resistance mechanisms in fluoroquinolone-resistant salmonella isolates from Germany. Antimicrob Agents Chemother 2003;47:2059.
15. Hansen H, Heisig P. Topoisomerase IV mutations in quinolone-resistant salmonellae selected in vitro. Microb Drug Resist 2003;9:25-32.
16. Nakaya H, Yasuhara A, Yoshimura K, Oshihoi Y, Izumiya H, Watanabe H. Life-threatening infantile diarrhea from fluoroquinolone-resistant Salmonella enterica typhimurium with mutations in both gyrA and parC. Emerg Infect Dis 2003;9:255-7.
17. Giraud E, Cloeckaert A, Kerboeuf D, Chaslus-Dancla E. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2000;44:1223-8.
18. Oethinger M, Kern WV, Jellen-Ritter AS, McMurry LM, Levy SB. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 2000;44:10-3.
19. Nikaido H, Basina M, Nguyen V, Rosenberg EY. Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains. J Bacteriol 1998;180:4686-92.
20. Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557-84.
21. Jaffe A, Chabbert YA, Semonin O. Role of porins proteins OmpF and OmpC in the permeation of beta-lactams. Antimicrob Agents Chemother 1982;22:942-8.
22. Pitout JD, Sanders CC, Sanders WEJ. Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. Am J Med 1997;103:51-9.
23. Navarro F, Pérez-Trallero E, Marimón JM, Aliaga R, Gomariz M, Mirelis B. CMY-2 producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). J Antimicrob Chemother 2001;48:383-9.
24. Simarro E, Navarro F, Ruiz J, Miró E, Gómez J, Mirelis B. Salmonella enterica serovar Virchow with CTX-M-like beta-lactamase in Spain. J Clin Microbiol 2000;38:4676-8.
25. Prats G, Mirelis B, Llovet T, Muñoz C, Miró E, Navarro F. Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona. Antimicrob Agents Chemother 2000;44:1140-5.
26. Gensberg K, Jin YF, Piddock LJV. A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium. FEMS Microbiol Lett 1995;132:293.
27. Piddock LJ, Griggs DJ, Hall MC, Jin YF. Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients. Antimicrob Agents Chemother 1993;37:662-6.
28. Wain J, Hoa NT, Chinh NT, Vinh H, Everett MJ, Diep TS, et al. Quinolone-resistant Salmonella typhi in Viet Nam: Molecular basis of resistance and clinical response to treatment. Clin Infect Dis 1997;25:1404-10.
29. Ruiz J, Capitano L, Núñez I, Castro D, Sierra J, Hatha M, et al. Mechanisms of resistance to ampicillin, chloramphenicol and quinolones in multiresistant Salmonella typhimurium strains isolated from fish. J Antimicrob Chemother 1999;43:699-702.
30. Pers C, Sogaard P, Pallesen L. Selection of multiple resistance in Salmonella enteritidis during treatment with ciprofloxacin. Scand J Infect Dis 1996;28:529-31.
31. Crump JA, Barrett TJ, Nelson JT, Angulo FJ. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin Infect Dis 2003;37:75-81.
32. Szybalski W, Bryson V. Genetic studies on microbial cross resistance to toxic agents. Cross resistance of Escherichia coli to fifteen antibiotics. J Bacteriol 1952;64:489-99.
33. Rasheed JK, Jay C, Metchock B, Berkowitz F, Weigel L, Crellin J, et al. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 1997;41:647-53.
34. Performance standards for antimicrobial disk susceptibility test; NCCLS document M2-A7. Wayne, Pa: National Committee for Clinical Laboratory Standards; 2000.
35. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard fifth edition. NCCLS document M7-A5. Wayne, Pa: National Committee for Clinical Laboratory Standards; 2000.
36. Miró E, Del Cuerpo M, Navarro F, Sabaté M, Mirelis B, Prats G. Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction. J Antimicrob Chemother 1998;42:535-8.
37. Heisig P. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 1996;40:879-85.
38. Martínez-Martínez L, Hernández-Allés S, Albertí S, Tomás JM, Benedí VJ, Jacoby GA. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrob Agents Chemother 1996;40:342-8.
39. Martínez-Martínez L, García I, Ballesta S, Benedí VJ, Hernández-Allés S, Pascual A. Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains. Antimicrob Agents Chemother 1998;42:1850-2.
40. Rodriguez F de C, Solís Cuesta F, Navarro F, Muñoz J, Tejero R, Ibarra González A, et al. Salmonella spp. Serotipos aislados en el Hospital Universitario Reina Sofía de Córdoba durante un período de 8 años (1993-2000). Enferm Infecc Microbiol Clin 2002;20:208-11.
41. Perez-Ciordia I, Ferrero M, Sánchez E, Abadías M, Martínez-Navarro F, Herrera D. Enteritis por Salmonella en Huesca. 1996-1999. Enferm Infecc Microbiol Clin 2002;20:16-21.
42. Martínez-Martínez L, Pascual A, Conejo MA, García I, Joyanes P, Doménech-Sánchez A, et al. Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relations-hip to extended-spectrum beta-lactamase production. Antimicrob Agents Chemother 2002;46:3926-32.
43. Sulavik MC, Dazer M, Miller PF. The Salmonella typhimurium mar locus: Molecular and genetic analyses and assessment of its role in virulence. J Bacteriol 1997;179:1857-66.
44. Doménech-Sánchez A, Martínez-Martínez L, Hernández-Allés H, Conejo MC, Pascual A, Tomás JM, et al. Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. Antimicrob Agents Chemother 2003; 47:3332-5.